Very glad to present our results of the HELIOS trial comparing chromoendoscopy 🔵 with HD white light 🟡 at the #ECCO2024 plenary hall!

✅ HDWLE with segmental re-inspection is non-inferior to chromoendoscopy

Lauranne Derikx Beatriz Gros Ashkan Rezazadeh MD Radboudumc Joost PH Drenth

Once from Edinburgh always from Edinburgh

Charlie Lees ShahidaDin Eleanor Burt Claire O’Hare Jonny Blackwell Nikolas Plevris Nathan Constantine-Cooke Lauranne Derikx #Chiara

#ECCO2024 🇸🇪 🪐

Another incredible meeting, filled with inspiring discussions and reconnecting with amazing friends in the #IBD field! 🪩

Edinburgh crew at ECCO

The author-corrected version of our CGH paper is now available (open access)! doi.org/10.1016/j.cgh.…

⚡️ ⁦Lauranne Derikx⁩ signs of the PhD 🎓 of ⁦Maarten te Groen⁩
✅ Very proud that she moves up the Academic 🪜
⁦Charlie Lees⁩

A massive thank you to ShahidaDin for taking part in the PhD dissertation of Maarten te Groen about colorectal neoplasia in IBD

Brilliant questions, brilliant answers

Looking forward to collaborate!

Brilliant thesis defense by Maarten te Groen, a huge milestone!

It was an honour to supervise and collaborate in the past 3 years. Looking forward to keep working together.

Many congratulations!

🆓 Our paper is now available as open access! 🆓

Some of our Edinburgh IBD unit posters 🤩🤩 fantastic work team!!!
Rebecca Hall Gwo Tzer Nathan Constantine-Cooke Charlie Lees Gareth-Rhys Jones ShahidaDin Eleanor Burt Edinburgh IBD Science Nikolas Plevris Lauranne Derikx Mathew Lyons Claire O’Hare

Not at #ECCO23 this year? This is our poster in which we identify distinctive faecal calprotectin profiles in IBD with over 2400 subjects (WIP, subject to change). We are looking for collaborators for validation/external cohorts! Interested? Please contact me or Charlie Lees.

Switching 🔁Biosimilars for # IBD
Multiple 🔃 switches 🔂feasible
Cheap(er)💰Effective & Feasible
🆕in @uegjournal

Lauranne Derikx Beatriz Gros Nikolas Plevris Gareth-Rhys Jones Charlie Lees @wileyhealth

onlinelibrary.wiley.com/journal/205064…

Multiple successive switches from IFX originator to biosimilars are effective and safe in patients with IBD, irrespective of the number of IFX switches. 🧵

Our paper is open for you to read.

onlinelibrary.wiley.com/doi/full/10.10…

Fantastic work by Beatriz Gros

Thank you for creating this amazingly helpful timeline with IBD studies.

Simply brilliant! 🙏

Thanks so much for sharing our work. Looking forward to seeing it published fully and make a 🧵 to explain it in detail 🤩🤩

In times of ⏫healthcare💰, check this out:

N=297 IBD 🏴󠁧󠁢󠁳󠁣󠁴󠁿
Multiple IFX originator to biosimilars switches demonstrated comparable:
1⃣ Clinical remission
2⃣ Biochemical (CRP) remission
3⃣ Faecal calprotectine values

➡️This will help reduce💰!

UEGJ 🔜 to be published🔥

8 exciting IBD molecules to look out for in 2023:

• therapies entering routine clinical practice
• key datasets emerging
• full publications
• notable trials

Also Triana IBD Lauranne Derikx congratulations for this big piece of work!!!!!!

Excited to see our paper on #quality of #surveillance in #IBD in press CGH🙌
🔥Inflammation ➡️ missed lesions
🏥Delays ➡️ advanced neoplasia
👉Compliance with quality indicators is essential for effective surveillance Lauranne Derikx Joost PH Drenth shorturl.at/dyJM4

Top 12 papers on gut inflammation from 2022

These are the scientific / translational papers that had the biggest impact on me this year

• Heavily focused on diet and the microbiome

• High quality science papers from nature Science Magazine and Cell